Gross Margin

Harvard Business Review's 2025 prize signals a new era for leadership, rewarding a practical framework that moves beyond AI hype to strategic implementation.

With new clinical trial data showing its AI is superior for complex AFib, Volta Medical heads to a major conference to change the standard of care.

Facing a storm of overcapacity, geopolitical risks, and a rising China, Europe's polyolefins sector is fighting for its future. Can it survive?

Outset Medical appoints Derick Elliott as commercial EVP, a strategic move to accelerate its Tablo dialysis system and capitalize on the hospital insourcing trend.

With diagnostic sales fueling a diverse therapeutic arsenal, Telix reaffirms blockbuster guidance and advances pivotal trials for prostate, brain, and kidney cancers.

The 6th-gen Toyota RAV4 ditches gas engines, betting its all-hybrid lineup and new tech can keep it on top of the hyper-competitive small SUV market.

Boston's Bio-IT World conference shifts from AI theory to execution, showcasing how the life sciences industry is now deploying AI to accelerate new therapies.

Amid financial headwinds, radiation therapy firm Accuray appoints a proven sales leader to spearhead a critical commercial transformation.

MTI replaces its Road Tour with an intense, invite-only forum, uniting top regulators and experts to find the next wave of healthcare solutions.

MetLife Investment Management hires Andrea Drasites from Blackstone to head its real estate arm, a strategic move to scale after its PineBridge acquisition.

Amidst major losses and a declining core business, China's Quhuo bets its future on a high-stakes pivot to housekeeping and vehicle exports, fueled by AI.

QuEra Computing has released Tsim, a powerful open-source simulator designed to tackle a major bottleneck in building fault-tolerant quantum computers.

HubSpot adds MongoDB CFO Mike Berry to its board, a strategic move to bolster financial discipline and guide its ambitious AI-driven global expansion.

The online car retail giant is creating new geographic clusters and promoting key leaders to accelerate its push for a single, efficient operating system.

Expanded Medicare payment for RefleXion's SCINTIX therapy removes major financial hurdles, opening doors for advanced cancer care in community centers.

The investment firm reports a 213% revenue surge after a major acquisition, but a 'going concern' note raises questions about its financial footing.

The tech firm posts impressive growth from defense and EV sectors, but a 'going concern' notice in its annual report reveals significant liquidity challenges.

With its pure-play chemical transition complete, Ascent adds two heavyweights to its board, signaling an aggressive new phase of growth and M&A.

LONGi unveils its all-in-one solar and storage system, aiming to simplify energy and challenge a fragmented market. But will customers buy into one vendor?

With a unique drug that preserves muscle while shedding fat, a newly fortified biotech is set to challenge the titans of the weight-loss market.